Cargando…
Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol
INTRODUCTION: Globally, rheumatic heart disease (RHD) is an important cause of acquired heart disease in children and adolescents. Clinical trials on RHD treatment with Traditional Chinese Medicine (TCM) or integrated medicine are gradually increasing in China. However, because the outcomes of clini...
Autores principales: | Sheng, Xiaodi, Chen, Chao, Ji, Zhaochen, Hu, Haiyin, Zhang, Mingyan, Wang, Hui, Pang, Bo, Zhai, Jingbo, Zhang, Dong, Zhang, Junhua, Guo, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660565/ https://www.ncbi.nlm.nih.gov/pubmed/36368756 http://dx.doi.org/10.1136/bmjopen-2022-062497 |
Ejemplares similares
-
PROSPERO's systematic review protocols of traditional Chinese medicine for COVID-19: An overview
por: Hu, Haiyin, et al.
Publicado: (2021) -
Treatment of Chronic Pulmonary Heart Disease with Traditional Chinese Medicine: A Protocol for the Development of a Core Outcome Set (COS-TCM-CPHD)
por: Niu, Bohan, et al.
Publicado: (2021) -
Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol
por: Zhang, Mingyan, et al.
Publicado: (2021) -
Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020) -
Clinical Research of Traditional Chinese Medicine Needs to Develop Its Own System of Core Outcome Sets
por: Zhang, Li, et al.
Publicado: (2013)